NeoMedLight Overview
- Year Founded
-
2014

- Status
-
Private
- Employees
-
8

- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2.64M
- Investors
-
4
NeoMedLight General Information
Description
Developer of medical devices designed to limit side effects and increase therapeutic efficiency in cancer treatment. The company's device utilizes the emission of light through the woven optic fiber to treat and prevent oral mucositis, radiodermatitis and dermatitis, enabling patients to be treated safely with precise control of treatment parameters and in a reproducible and consistent manner.
Contact Information
Website
www.neomedlight.comCorporate Office
- 88-90 Rue Frédéric Faÿs
- 69100 Villeurbanne
- France
Corporate Office
- 88-90 Rue Frédéric Faÿs
- 69100 Villeurbanne
- France
NeoMedLight Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Grant | 25-Oct-2019 | $2.64M | Completed | Pre-Clinical Trials | ||
1. Early Stage VC | 13-Jan-2015 | Completed | Startup |
NeoMedLight Patents
NeoMedLight Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
FR-3105006-B1 | Luminous applicator for a treatment by phototherapy, associated control unit and corresponding treatment system | Active | 19-Dec-2019 | ||
EP-4076642-A1 | Light applicator for use in a light therapy treatment, control unit and treatment system thereof | Pending | 19-Dec-2019 | ||
FR-3105006-A1 | Luminous applicator for treatment by phototherapy, associated control unit and corresponding treatment system | Active | 19-Dec-2019 | ||
EP-3171940-B1 | Single-patient textile device for phototherapy treatment and unit comprising such a single-patient textile device | Active | 25-Jul-2014 | ||
EP-3171940-A1 | Single-patient textile device for phototherapy treatment and unit comprising such a single-patient textile device | Active | 25-Jul-2014 | A61N5/0621 |
NeoMedLight Signals
NeoMedLight Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Horizon 2020 SME Instrument | Government | |||
Angelor | Angel Group | Minority | ||
Health-angels Rhone-alpes | Angel Group | Minority | ||
Smalt Capital | Asset Manager | Minority |
NeoMedLight FAQs
-
When was NeoMedLight founded?
NeoMedLight was founded in 2014.
-
Where is NeoMedLight headquartered?
NeoMedLight is headquartered in Villeurbanne, France.
-
What is the size of NeoMedLight?
NeoMedLight has 8 total employees.
-
What industry is NeoMedLight in?
NeoMedLight’s primary industry is Therapeutic Devices.
-
Is NeoMedLight a private or public company?
NeoMedLight is a Private company.
-
What is NeoMedLight’s current revenue?
The current revenue for NeoMedLight is
. -
How much funding has NeoMedLight raised over time?
NeoMedLight has raised $3.63M.
-
Who are NeoMedLight’s investors?
Horizon 2020 SME Instrument, Angelor, Health-angels Rhone-alpes, and Smalt Capital have invested in NeoMedLight.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »